Uterus contraction medicine study during planned C-sections
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study looks at how well different doses of a contraction medicine work after an initial dose in women having a planned C-section. It may help find the best way to prevent bleeding after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 37 and 41 weeks pregnant
- You are not in labor and have not received oxytocin (a labor-inducing medicine)
- You are having a planned first or second C-section under spinal anesthesia
- You have not had any other uterine surgery or more than one previous C-section
- You do not have placenta accreta (a condition where the placenta grows too deeply into the uterus)
- You are not taking certain medicines like insulin, nifedipine, labetalol, or magnesium sulfate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how three medications (ephedrine, phenylepinephrine, and norepinephrine) affect the contraction strength of uterine muscle tissue from pregnant people with type 2 or gestational diabetes during planned C-sections. It aims to understand if these drugs act differently in people with diabetes, which could help tailor safer treatments for low blood pressure during surgery.
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
This study compares two medications given right after vaginal delivery to prevent heavy bleeding (postpartum hemorrhage). The goal is to find which one works better for women who have a higher risk of bleeding after childbirth.
This study tests whether giving a medication (misoprostol) rectally during a planned C-section can help reduce blood loss after delivery. It may help women have a safer recovery with less bleeding.
This study compares two ways of giving the medicine oxytocin (which helps the womb tighten to reduce bleeding) after a C-section in women at high risk for heavy bleeding. It will see if giving it as a single injection or as a slow drip works better at preventing excessive blood loss.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.